Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Maytenus senegalensis is a medicinal plant belonging to the Celastraceae family. It is a shrub or tree that grows up to 15 meters high and is widely distributed across Africa, Arabia, Afghanistan, and India. The plant has been traditionally used in African medicine for treating various ailments including malaria, inflammation, respiratory diseases, and infectious diseases. Scientific studies have confirmed its antimalarial, antibacterial, and anti-inflammatory properties, with maytenoic acid being identified as a key anti-inflammatory compound. Clinical trials have demonstrated that M. senegalensis is safe and tolerable when administered at a dose of 800 mg every eight hours for four days, with no serious adverse events reported.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on maytenus senegalensis.